abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
91866: BRCAvantage™, Rearrangements Print View
Known Family BRCA Mutation      
Spec. Familial Del/Dup      
Interpretation Summary      
BRCA1 Del/Dup MICROARRAY     
BRCA1 Del/Dup Interp      
BRCA2 Del/Dup MICROARRAY     
BRCA2 Del/Dup Interp      
Comprehensive Interp      
Additional Information      

PRIMARY
1 Whole Blood EDTA 4 (2) mL   Refrigerated - 8 Day(s)/Room Temperature - 8 Day(s)  
ALTERNATE

Hereditary Breast and Ovarian Cancer syndrome is caused by sequence mutations or large deletion/duplication mutations in the BRCA1 gene and the BRCA2 gene. This test detects large deletion/duplication mutations in the BRCA1 and BRCA2 genes that are not detectable by DNA sequencing.

Whole Blood: Normal phlebotomy procedure; specimen stability is
crucial. Store and ship room temperature immediately. Do not
freeze. Send report of results for family member with known BRCA
mutation.
Setup Schedule
Tuesday, Thursday, Saturday

Reported (Analytical Time)
12 days

CPT Codes
81213,81479

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Method: Microarray Report available: 12 days from completed pre-authorization






© 1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database